Paul Tudor Jones Teva Pharmaceutical Industries LTD Transaction History

Tudor Investment Corp Et Al

$26.8 Billion
Q3 2024

A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 815,001 shares of TEVA stock, worth $18.2 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

815,001

Previous 855,001 4.68%

Holding current value

$18.2 Million

Previous $13.9 Million 5.71%

% of portfolio

0.05%

Previous 0.07%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.81 - $18.96 $632,400 - $758,400	-40,000 Reduced 4.68%	815,001 $14.7 Million
Q2 2024 Aug 14, 2024	SELL	$12.78 - $17.4 $1.15 Million - $1.57 Million	-90,048 Reduced 9.53%	855,001 $13.9 Million
Q1 2024 May 15, 2024	SELL	$10.67 - $14.43 $120,442 - $162,885	-11,288 Reduced 1.18%	945,049 $13.3 Million
Q4 2023 Feb 14, 2024	BUY	$8.12 - $10.63 $502,108 - $657,316	61,836 Added 6.91%	956,337 $9.98 Million
Q3 2023 Nov 15, 2023	BUY	$7.48 - $10.7 $1.56 Million - $2.23 Million	208,776 Added 30.45%	894,501 $9.12 Million
Q2 2023 Aug 14, 2023	SELL	$7.2 - $9.47 $3.4 Million - $4.47 Million	-472,253 Reduced 40.78%	685,725 $5.16 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $99,141 - $134,836	11,859 Added 1.03%	1,157,978 $10.2 Million
Q4 2022 Feb 14, 2023	BUY	$7.95 - $9.48 $167,204 - $199,383	21,032 Added 1.87%	1,146,119 $10.5 Million
Q3 2022 Nov 14, 2022	BUY	$6.86 - $11.95 $68,600 - $119,500	10,000 Added 0.9%	1,125,087 $9.08 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $3.06 Million - $4.32 Million	415,000 Added 59.28%	1,115,087 $8.39 Million
Q1 2022 May 16, 2022	BUY	$7.33 - $9.39 $5.13 Million - $6.57 Million	700,087 New	700,087 $6.57 Million
Q4 2020 Feb 16, 2021	SELL	$8.61 - $11.04 $87,598 - $112,320	-10,174 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$8.57 - $12.69 $87,191 - $129,108	10,174 New	10,174 $92,000
Q2 2020 Aug 14, 2020	SELL	$8.12 - $13.12 $82,011 - $132,512	-10,100 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$6.69 - $13.45 $3,318 - $6,671	-496 Reduced 4.68%	10,100 $91,000
Q4 2019 Feb 14, 2020	BUY	$6.53 - $10.72 $69,191 - $113,589	10,596 New	10,596 $104,000

Others Institutions Holding TEVA

# of Institutions

625

Shares Held

573M

Call Options Held

19.6M

Put Options Held

6.77M

View Full List

About TEVA PHARMACEUTICAL INDUSTRIES LTD

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $24.8B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

More about TEVA

Track Paul Tudor Jones's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.

Account